BiotinTeam
24 Eki 2024
The BIOTIN team participated in BIOEXPO 2024, Turkey’s premier biotechnology event, which provided a dynamic environment for fellows to explore the latest advancements in biomedical technologies. This event brought together leading biotech companies, startups, and research institutions, allowing fellows to witness cutting-edge innovations in biopharmaceuticals, diagnostic devices, and regenerative medicine.
BIOEXPO presented a unique opportunity for BIOTIN fellows to engage directly with industry leaders, technology developers, and investors. By attending company showcases and networking sessions, fellows were able to explore potential collaborations, understand market needs, and gain insight into the commercialization process of biomedical research. The exhibition featured a wide range of state-of-the-art medical devices, next-generation therapeutics, and biomanufacturing solutions, all of which align with BIOTIN’s mission of fostering entrepreneurial scientists in biotechnology.
A significant highlight of BIOEXPO was the opening speech by Prof. Volga Bulmuş, the coordinator of the BIOTIN project. Prof. Bulmuş provided an overview of BIOTIN’s mission, objectives, and the crucial role of industry-academia collaboration in fostering the next generation of biotech entrepreneurs. This speech set the tone for the event, emphasizing the importance of interdisciplinary research and commercialization pathways in biomedical technologies.
A key session of the event was the presentation by AMGEN Türkiye, a leading global biotechnology company and a crucial partner of the BIOTIN project. Dr. Mehmet Tural, Senior Medical Manager at AMGEN, delivered an insightful talk titled The Biotechnology Revolution: A New Era in the Pharmaceutical Industry. This session provided an in-depth overview of the evolution of biopharmaceuticals, cutting-edge drug development strategies, and the impact of personalized medicine.
AMGEN, known for its groundbreaking work in biologics and innovative therapeutics, plays a significant role in shaping the future of cancer treatments, autoimmune disease therapies, and rare disease solutions. Through its collaboration with BIOTIN, AMGEN is actively contributing to the development of entrepreneurial skills among early-career researchers and supporting the transformation of scientific discoveries into real-world medical applications.
Attending BIOEXPO and participating in AMGEN’s presentation provided BIOTIN fellows with a comprehensive view of the biotechnology industry's landscape, emphasizing key aspects such as research-to-market pathways, regulatory challenges, and industry-driven innovation. This experience reinforced the importance of industry-academia collaboration and equipped fellows with practical knowledge on how to navigate the commercial biotech sector, preparing them for their future roles as biotech entrepreneurs.
